期刊文献+

活性氧生成在卡铂诱导HN-3人喉鳞癌细胞凋亡中的作用

Role of reactive oxygen series generation in the apoptosis of HN-3 human laryngeal carcinoma cells induced by carboplatin
下载PDF
导出
摘要 目的观察卡铂(carboplatin)对HN-3人喉鳞癌细胞体外增殖的抑制作用、凋亡诱导,探讨活性氧生成在其中的作用。方法用卡铂以不同孵育浓度、不同孵育时间处理HN-3细胞,四甲基偶氮唑盐(MTT)法测定细胞活力,2',7'二氯氢化荧光素已二脂(H2DCFDA)染色测定活性氧生成,Hoechst/PI双重染色检测细胞凋亡/坏死情况,蛋白印迹法(Western blotting)测定多聚ADP-核糖聚合酶(PARP)表达。结果卡铂对体外培养的HN-3细胞有增殖抑制作用,呈剂量依赖性和时间依赖性;卡铂诱导HN-3细胞活性氧生成及凋亡呈时间与剂量依赖性;卡铂诱导氧化压力下PARP表达上调。结论卡铂可抑制人喉鳞癌HN-3细胞增殖,诱导HN-3细胞凋亡,其机制可能与卡铂诱导HN-3细胞活性氧生成及氧化压力下PARP表达上调有关。 Objective To investigate the role of reactive oxygen series (ROS) in suppressing cell viability and inducing apoptosis of HN-3 human laryngeal squamous carcinoma cells induced by carboplatin. Methods The attached HN-3 cancer cells were treated with different concentrations of carboplatin for 24 h and 0.08 mg/mL carboplatin at indicated time points. Methyl thiazolyl tetrazolium(MTF) assay was used to detect cellular viability. H2DCFDA staining and Hoechst 33343/PI double staining were performed to monitor reactive oxygen series (ROS) generation and apoptosis/ necrosis, respectively. Western blotting technique was used to assess the expression of poly ADP-ribose polymerase (PARP). Results Suppression of cellular viability on HN-3 cells induced by carboplatin was exhibited in a dose and time related pattern. Remarkable generation of ROS and apoptosis of HN-3 cells were initiated by carboplatin in dose and time related manner. Up-regulated expression of PARP under oxidative stress, induced by carboplatin, was partially inhibited by co-incubated with glutathione. Conclusions Generation of ROS and up-regulated PARP may play an important role in the suppression of cellular viability and apoptosis induction of HN-3 cells exerted by carboplatin.
出处 《中国眼耳鼻喉科杂志》 2015年第6期384-387,共4页 Chinese Journal of Ophthalmology and Otorhinolaryngology
基金 国家自然科学基金面上项目(81172557) 教育部留学回国人员科研启动基金(第45批)
关键词 喉鳞癌 卡铂 活性氧 凋亡 多聚ADP-核糖聚合酶 Laryngeal squamous cell carcinoma Carboplatin Reactive oxygen series Apoptosis Poly ADP-ribose polymerase
  • 相关文献

参考文献10

  • 1Rajeswaran A, Trojan A. Bumand B, et al. Efficacy and side effectsof cisplatin- and carboplatin-based doublet chemotherapeuticregimens versus non-platinum-based doublet chemotherapeuticregimens as first line treatment of metastatic non-small cell lungcarcinoma: a systematic review of randomized controlled trials [ J ].Lung Cancer,2008 ,59( 1) :1-11.
  • 2Kim SY, Chu KC, Lee HR, et al. Establishment andcharacterization of nine new head and neck cancer cell lines [ J ].Acta Otolaryngol, 1997,117(5) :775-784.
  • 3He P, Ahn JC, Shin JI, et al. Enhanced apoptotic effect ofcombined modality of 9 -hydroxypheophorbide alpha-mediatedphotodynamic therapy and carboplatin on AMC-HN-3 human headand neck cancer cells[ J]. Oncol Rep, 2009,21 (2) ;329-334.
  • 4Afri M,Frimer AA, Cohen Y. Active oxygen chemistry within theliposomal bilayer. Part IV: locating 2', 7^dichlorofluorescein(DCF), 2', T'-dichlorodihydrofluorescein ( DCFH ) and 2:7,-dichlorodihydrofluorescein diacetate ( DCFH-DA) in the lipid bilayer[J]. Chem Phys Lipids, 2004 ,131 ( 1) : 123-133.
  • 5Hato SV, Khong A, de Vries U, et al. Molecular pathways : theimmunogenic effects of platinum-based chemotherapeutics [ J ]. ClinCancer Res, 2014,20( 11) :2831-2837.
  • 6Finkel T. Oxidant signals and oxidative stress [ J]. Curr Opin CellBiol, 2003,15(2) :247-254.
  • 7Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer :initiators, amplifiers or an Achilles' heel? [ J]. Nat Rev Cancer,2014,14(11) :709-721.
  • 8He P, Ahn JC, Shin JI, et al. PKotoactivation of 9-hydroxypheophorbide alpha triggers apoptosis through the reactiveoxygen species-mediated mitochondrial pathway and endoplasmicreticulum stress in AMC-HN-3 laryngeal cancer cells [ J ]. Int JOncol, 2010,36(4) :801-808.
  • 9Rizvi I,Celli JP, Evans CL, et al. Synergistic enhancement ofcarboplatin efficacy with photodynamic therapy in a three-dimensionalmodel for micrometastatic ovarian cancer[ J]. Cancer Res, 2010,70(22):9319-9328.
  • 10Grilley-Olson JE,Keedy VL, Sandler A, et al. A randomized phaseII study of carboplatin with weekly or every-3-week nanoparticlealbumin-bound paclitaxel ( abraxane) in patients with extensive-stagesmall cell lung cancer[ J]. Oncologist, 2015 ,20(2) : 105-106.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部